Astrazeneca (AZNCF) Operating Margin (2016 - 2025)
Historic Operating Margin for Astrazeneca (AZNCF) over the last 16 years, with Q4 2025 value amounting to 19.21%.
- Astrazeneca's Operating Margin rose 55400.0% to 19.21% in Q4 2025 from the same period last year, while for Dec 2025 it was 23.4%, marking a year-over-year increase of 49000.0%. This contributed to the annual value of 23.4% for FY2025, which is 49000.0% up from last year.
- Astrazeneca's Operating Margin amounted to 19.21% in Q4 2025, which was up 55400.0% from 23.59% recorded in Q3 2025.
- Over the past 5 years, Astrazeneca's Operating Margin peaked at 699.44% during Q3 2022, and registered a low of 16.97% during Q3 2021.
- In the last 5 years, Astrazeneca's Operating Margin had a median value of 21.37% in 2023 and averaged 99.93%.
- In the last 5 years, Astrazeneca's Operating Margin surged by 7164100bps in 2022 and then tumbled by -6824400bps in 2023.
- Quarter analysis of 5 years shows Astrazeneca's Operating Margin stood at 2.43% in 2021, then soared by 28581bps to 692.41% in 2022, then tumbled by -99bps to 10.26% in 2023, then soared by 33bps to 13.67% in 2024, then soared by 40bps to 19.21% in 2025.
- Its Operating Margin stands at 19.21% for Q4 2025, versus 23.59% for Q3 2025 and 24.27% for Q2 2025.